Express Scripts Holding Company (ESRX) EPS Estimated At $1.76

April 26, 2018 - By Hazel Jackson

Express Scripts Holding Company (NASDAQ:ESRX) LogoInvestors sentiment increased to 0.69 in Q4 2017. Its up 0.07, from 0.62 in 2017Q3. It is positive, as 68 investors sold Express Scripts Holding Company shares while 407 reduced holdings. 111 funds opened positions while 216 raised stakes. 479.40 million shares or 1.52% less from 486.80 million shares in 2017Q3 were reported.
Tdam Usa Inc reported 33,997 shares or 0.15% of all its holdings. British Columbia Management Corporation invested 0.12% in Express Scripts Holding Company (NASDAQ:ESRX). Koch Incorporated holds 0.18% or 16,178 shares. Logan Capital Mngmt, a Pennsylvania-based fund reported 33,744 shares. Sun Life owns 1,241 shares. Cibc World Mkts Inc owns 28,944 shares or 0.01% of their US portfolio. Cwm Ltd Limited Liability Company has invested 0.01% in Express Scripts Holding Company (NASDAQ:ESRX). Hemenway Company Lc holds 0.04% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 2,970 shares. Optimum Invest reported 0.11% stake. Fiduciary Tru accumulated 171,519 shares. Vident Invest Advisory Ltd Limited Liability Company reported 0.18% stake. Riverhead Mgmt, a Delaware-based fund reported 223,568 shares. Clark Estates Inc Ny invested 0.65% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Moreover, Ngam Advsr L P has 0.03% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 39,677 shares. Moreover, Cibc World Mkts has 0.13% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 245,857 shares.

Analysts expect Express Scripts Holding Company (NASDAQ:ESRX) to report $1.76 EPS on May, 2 after the close.They anticipate $0.43 EPS change or 32.33 % from last quarter’s $1.33 EPS. ESRX’s profit would be $988.29M giving it 10.87 P/E if the $1.76 EPS is correct. After having $2.16 EPS previously, Express Scripts Holding Company’s analysts see -18.52 % EPS growth. The stock increased 1.36% or $1.03 during the last trading session, reaching $76.52. About 1.59M shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since April 26, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Express Scripts Holding Company (NASDAQ:ESRX) Ratings Coverage

Among 15 analysts covering Express Scripts Holding (NASDAQ:ESRX), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Express Scripts Holding had 26 analyst reports since December 4, 2017 according to SRatingsIntel. Bernstein downgraded Express Scripts Holding Company (NASDAQ:ESRX) on Tuesday, January 30 to “Sell” rating. The firm earned “Hold” rating on Thursday, December 14 by RBC Capital Markets. The firm has “Market Perform” rating given on Monday, March 12 by Bernstein. SunTrust maintained the shares of ESRX in report on Thursday, December 14 with “Buy” rating. As per Wednesday, January 31, the company rating was upgraded by RBC Capital Markets. The stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Market Perform” rating given on Wednesday, December 6 by Bernstein. Jefferies maintained Express Scripts Holding Company (NASDAQ:ESRX) on Friday, December 15 with “Buy” rating. On Friday, March 9 the stock rating was upgraded by Wells Fargo to “Hold”. Maxim Group downgraded the shares of ESRX in report on Thursday, March 8 to “Hold” rating. The company was maintained on Thursday, January 11 by SunTrust.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe. The company has market cap of $42.97 billion. It operates in two divisions, PBM and Other Business Operations. It has a 9.89 P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.